semaglutide, chronic kidney disease, and diabetes | nejm
Published 3 weeks ago • 2.5K plays • Length 1:56Download video MP4
Download video MP3
Similar videos
-
2:18
semaglutide and cardiovascular outcomes in obesity | nejm
-
2:05
semaglutide in heart failure with obesity | nejm
-
1:54
semaglutide and cardiovascular risks
-
40:56
cardiovascular and renal outcomes in type 2 diabetes medications with dr. marie mcdonnell
-
0:54
ask the expert – how do you choose the right medical treatment for diabetes?
-
0:42
semaglutide for chronic kidney disease and type 2 diabetes (flow trial).
-
1:57
semaglutide in adolescents with obesity | nejm
-
7:35
cardiac & renal outcomes with efpeglenatide in diabetes (amplitude-o) | nejm | med journal club
-
2:01
glycemia reduction approaches in type 2 diabetes | nejm
-
1:42
the scale trial
-
3:22
flow trial results on semaglutide use in those with kidney disease finally fully published!
-
8:14
tirzepatide versus semaglutide in type 2 diabetes (surpass-2) | nejm | med journal club
-
1:09
semaglutide (ozempic) and kidney disease! flow trial!
-
28:17
chronic kidney disease and glp-1 ras
-
0:32
a medication for type 2 diabetes, weight loss, kidney, and heart disease?!
-
8:35
ozempic and its impact on kidney disease: what you need to know
-
16:16
semaglutide -novel anti obesity medication for weight loss landmark study by nejm